A Prescription for Change: Citizens United’s Implications for Regulation of Off-Label Promotion of Prescription Pharmaceuticals

Journal of Law & Policy, Vol. 19, p. 867, 2011

46 Pages Posted: 22 Jul 2011  

Kristie Anne LaSalle

affiliation not provided to SSRN

Date Written: June 1, 2011

Abstract

This Note examines the complex regulatory structure that controls off-label promotion of prescription pharmaceuticals. Using the recent case of United States v. Caronia as an example of the unconstitutional shortcomings of this regulatory scheme, the Note analogizes the FDA's obstruse regulatory scheme to the corporate campaign contributions limitations struck down in Citizens United v. FEC, and argues that the same logic applied in Citizens United should be applied to the regulation of truthful speech regarding prescription pharmaceuticals.

Keywords: pharmaceuticals, Citizens United v. FEC, United States v. Caronia, first amendment

Suggested Citation

LaSalle, Kristie Anne, A Prescription for Change: Citizens United’s Implications for Regulation of Off-Label Promotion of Prescription Pharmaceuticals (June 1, 2011). Journal of Law & Policy, Vol. 19, p. 867, 2011. Available at SSRN: https://ssrn.com/abstract=1891992

Kristie Anne LaSalle (Contact Author)

affiliation not provided to SSRN ( email )

Paper statistics

Downloads
43
Abstract Views
402